Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BF.5.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BF.5.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.5.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BN.1.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BN.1.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BN.1.3.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.513NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.513NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.513NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.338NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.338NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.338NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.284NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.284NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.284NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.9.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.9.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.9.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.498NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.498NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.498NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.184NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.184NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.184NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.187NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.187NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.187NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
D.3NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
D.3NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
D.3NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.110.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.110.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.110.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.342NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.342NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.342NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.500NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.500NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.500NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.511NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.511NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.511NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.428.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.428.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.428.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.506NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used